Numerai has successfully raised $30 million in a Series C funding round, led by several university endowment funds. This latest investment values the company at $500 million, a fivefold increase from its 2023 valuation. Existing investors, including Union Square Ventures, Shine Capital, and Paul Tudor Jones, also participated in the round. In addition to the funding, Numerai has secured up to $500 million in capacity support from JPMorgan and has repurchased $1 million worth of its NMR tokens from the open market.